|
1
|
Mymrikov EV, Seit-Nebi AS and Gusev NB:
Large potentials of small heat shock proteins. Physiol Rev.
91:1123–1159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor RP and Benjamin IJ: Small heat
shock proteins: a new classification scheme in mammals. J Mol Cell
Cardiol. 38:433–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kato K, Shinohara H, Goto S, Inaguma Y,
Morishita R and Asano T: Copurification of small heat shock protein
with αB crystallin from human skeletal muscle. J Biol Chem.
267:7718–7725. 1992.PubMed/NCBI
|
|
4
|
Kato K, Hasegawa K, Goto S and Inaguma Y:
Dissociation as a result of phosphorylation of an aggregated form
of the small stress protein, hsp27. J Biol Chem. 269:11274–11278.
1994.PubMed/NCBI
|
|
5
|
Kato K, Goto S, Inaguma Y, Hasegawa K,
Morishita R and Asano T: Purification and characterization of a
20-kDa protein that is highly homologous to a B crystallin. J Biol
Chem. 269:15302–15309. 1994.PubMed/NCBI
|
|
6
|
Vos MJ, Hageman J, Carra S and Kampinga
HH: Structural and functional diversities between members of the
human HSPB, HSPH, HSPA and DNAJ chaperone families. Biochemistry.
47:7001–7011. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berndt MC, Shen Y, Dopheide SM, Gardiner
EE and Andrews RK: The vascular biology of the glycoprotein Ib-IX-V
complex. Thromb Haemost. 86:178–188. 2001.PubMed/NCBI
|
|
8
|
Garcia A, Quinton TM, Dorsam RT and
Kunapuli SP: Src family kinase-mediated and Erk-mediated
thromboxane A2 generation are essential for vWF/GPIb-induced
fibrinogen receptor activation in human platelets. Blood.
106:3410–3414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong JF, Berndt MC, Schade A, McIntire LV,
Andrews RK and Lopez JA: Ristocetin-dependent, but not
botrocetin-dependent, binding of von Willebrand factor to the
platelet glycoprotein Ib-IX-V complex correlates with
shear-dependent interactions. Blood. 97:162–168. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Enomoto Y, Adachi S, Matsushima-Nishiwaki
R, Doi T, Niwa M, Akamatsu S, et al: Thromboxane A2 promotes
soluble CD40 ligand release from human platelets. Atherosclerosis.
209:415–421. 2010. View Article : Google Scholar
|
|
11
|
Kozawa O, Matsuno H, Niwa M, Hatakeyama D,
Kato K and Uematsu T: αB-crystallin, a low-molecular-weight heat
shock protein, acts as a regulator of platelet function. Cell
Stress Chaperones. 6:21–28. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuno HI, Ishisaki A, Nakajima K, Kato K
and Kozawa O: A peptide isolated from αB-crystallin is a novel and
potent inhibitor of platelet aggregation via dual prevention of
PAR-1 and GPIb/V/IX. J Thromb Haemost. 12:2636–2642. 2003.
View Article : Google Scholar
|
|
13
|
Enomoto Y, Adachi S, Matsushima-Nishiwaki
R, Niwa M, Tokuda H, Akamatsu S, et al: Alpha B-crystallin
extracellularly suppresses ADP-induced granule secretion from human
platelets. FEBS Lett. 583:2464–2468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ward CM, Andrews RK, Smith AI and Berndt
MC: Mocarhagin, a novel cobra venom metalloproteinase, cleaves the
platelet von Willebrand factor receptor glycoprotein Iba.
Identification of the sulfated tyrosine/anionic sequence
Tyr-276-Glu-282 of glycoprotein Iba as a binding site for von
Willebrand factor and a-thrombin. Biochemistry. 35:4929–4938. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fabre JE, Nguyen M, Latour A, Keifer JA,
Audoly LP, Coffman TM and Koller BH: Decreased platelet
aggregation, increased bleeding time and resistance to
thromboembolism in P2Y1-deficient mice. Nature Med. 5:1199–1202.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and α B-crystallin by cyclic AMP in C6 rat glioma cells. J
Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Catella F, Healy D, Lawson JA and
FitzGerald GA: 11-Dehydrothromboxane B2: a quantitative index of
thromboxane A2 formation in the human circulation. Proc Natl Acad
Sci USA. 83:5861–5865. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bertele V, Di Minno G and de Gaetano G:
U-46619, a stable analogue of prostaglandin H2, induces retraction
of human platelet-rich plasma clots. Thromb Res. 18:543–545. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gangalum RK, Atanasov IC, Zhou ZH and Bhat
SP: αB-crystallin is found in detergent-resistant membrane
microdomains and is secreted via exosomes from human retinal
pigment epithelial cells. J Biol Chem. 286:3261–3269. 2011.
View Article : Google Scholar :
|
|
21
|
Nakahata N: Thromboxane A2:
physiology/pathophysiology, cellular signal transduction and
pharmacology. Pharmacol Ther. 118:18–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doi T, Tokud H, Matsushima-Nishiwaki R,
Cuong NT, Kageyama Y, Iida Y, Kono A, Akamatsu S, Otsuka T, Iida H,
Kozawa O and Ogura S: Effect of antithrombin III on glycoprotein
Ib/IX/V activation in human platelets: suppression of thromboxane
A2 generation. Prosta Leukot Essent Fatty Acids. 87:57–62. 2012.
View Article : Google Scholar
|
|
23
|
Davi G and Patrono C: Platelet activation
and atherothrombosis. New Engl J Med. 357:2482–2494. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hermann A, Rauch BH, Braun M, Schror K and
Weber AA: Platelet CD40 ligand (CD40 L)-subcellular localization,
regulation of expression and inhibition by clopidogrel. Platelets.
12:74–82. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Henn V, Slupsky JR, Grafe M,
Anagnostopoulos I, Forster R, Muller-Berghaus G, et al: CD40 ligand
on activated platelets triggers an inflammatory reaction of
endothelial cells. Nature. 391:591–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heeschen C, Dimmeler S, Hamm CW, van den
Brand MJ, Boersma E, Zeiher AM, et al: Soluble CD40 ligand in acute
coronary syndromes. New Engl J Med. 348:1104–1111. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varo N, de Lemos JA, Libby P, Morrow DA,
Murphy SA, Nuzzo R, et al: Soluble CD40L: risk prediction after
acute coronary syndromes. Circulation. 108:1049–1052. 2003.
View Article : Google Scholar : PubMed/NCBI
|
